Session Item

Monday
May 09
12:45 - 14:15
Auditorium 15
Increasing the impact of your research
Daniel Portik, The Netherlands;
Ludwig Dubois, The Netherlands
How to increase the impact of your research? An important question that puzzles both young and more established researchers. During the yESTRO lunch symposium, some guides will be presented how to pitch your research, how to write a successful grant application and how and why to involve patients and public. In the “thinking out-of-the-box” sub-session, two experienced (implementation) researchers will enlighten us about the usefulness of other disciplines for your research projects.
Young lunch symposium + networking
Young
Prototype testing the 3D-printed Montreal split-ring applicator (GYN) using biocompatible materials
PO-0192

Abstract

Prototype testing the 3D-printed Montreal split-ring applicator (GYN) using biocompatible materials
Authors:

Yuji Kamio1, Marie-Ève Roy1, Lauri-Anne Morgan2, Maroie Barkati1, Marie-Claude Beauchemin1, Jean-François Carrier3, Borko Basaric2, François DeBlois1, Stephane Bedwani1

1Centre Hospitalier de l'Université de Montréal, Radiation Oncology, Montreal, Canada; 2Adaptiiv Medical Technologies, Inc. , Brachytherapy Solutions, Halifax, Canada; 3University of Montreal, Physics, Montreal, Canada

Show Affiliations
Purpose or Objective

An adaptive technique combining intracavitary GYN applicators with interstitial needles is associated with improved outcomes in locally advanced cervical cancer involving tumor extensions to the parametrium. The multicenter EMBRACE II study protocol provides dose constraints as planning aims and dose limits for MR-delineated target structures. Expensive applicators needed to perform combined intracavitary/interstitial (IC/IS) brachytherapy and achieve the EMBRACE II planning aims are only available in a few specialized centers limiting the adoption of IC/IS brachytherapy. The purpose of this work is to show the feasibility of upgrading a widely used IC-only applicator; the CT/MR split-ring (E&Z BEBIG, Berlin, Germany) using relatively inexpensive 3D-printing technology to enable a more widespread and patient-specific use of IC/IS brachytherapy.  

Material and Methods

The CT/MR split-ring applicator comes with disposable or reusable buildup caps that work as sleeves for each split-rings. A CAD model of the standard 5 mm buildup cap was designed using Fusion 360TM (Autodesk Inc., California, USA). The cap was then extended outward and notches were modeled to allow attachment of guiding tubes used with the interstitial lunar ovoids of the Venezia IC/IS applicator (Elekta, Stockholm, Sweden). These upgraded sleeves were then printed using a Form3 SLA printer (Formlabs Inc., Massachusetts, USA) using two resins; Surgical Guide (ISO 10993 biocompatibility & 50 μm resolution) and BioMed Clear (USP Class VI biocompatibility & 100 μm resolution). Sleeves were steam sterilized at 132 °C in an autoclave for 4 minutes followed by a 25 minutes dry phase. Finally, the sleeves were tested for the following properties both pre- and post-sterilization: split-ring, guide-tube and fixation screw attachment.  

Results

Figure 1. and 2. show the upgraded split-ring IC/IS applicator with the Surgical Guide and BioMed Clear sleeves respectively. Successful insertion of each split-rings and attachment of interstitial guide tubes was verified both pre- and post-sterilization. Guiding tube notches for interstitial needle obliquity angles of 15°, 30° and 45° were successfully tested. Fixation screw threads were found to be the most sensitive features of the printed sleeves. However, optimizing the protocol/models we increased the number of times the screw can be re-used before stripping the threads to over ten times which is satisfactory considering the disposable nature of these sleeves.  






Conclusion

3D-printing technology was successfully used to produce the affordable 3D-printed Montreal split-ring applicator for combined IC/IS brachytherapy. A collaboration is ongoing to develop a dedicated software module in Adaptiiv’s brachytherapy software (Adaptiiv Medical Technologies, Inc., Halifax, Canada) that would allow patient-specific needle trajectories (obliquity angles 45°) for adaptive brachytherapy.